4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0002083206-26-000007
Chief Financial Officer sold 4,117 shares at $4.91 ($20,203)
From the SEC's structured data for this filing
Trades in this filing
Tamayo Louis Edward · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-18 | Sale : show line 1 in the form | −4,117 | $4.91 | $20,203 | 92,907 | D |
| Open-market sales · 4,117 sh · avg $4.91 · $20,203 | ||||||
Loading xslF345X06/form4-08192026_050809.xml…